Most stroke and transient ischaemic attack (TIA) survivors are asked to take medicines, which some can find difficult. However, taking the medicines prescribed after a stroke, or TIA, and following lifestyle advice can reduce the chance of another stroke by 80%.
Senior Research Training Fellowship: Dr Euan Sadler
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home, co-ordinated by a team of therapists, nurses and a doctor. A number of ESD services have been set up across England. Do these services offer the same benefits to patients as those identified in clinical trials?
About one third of stroke survivors are left with aphasia. This is a language disorder that disrupts the production and comprehension of speech, as well as reading and writing. This study will investigate whether a support group intervention can be delivered remotely to people with aphasia through a virtual island platform called Eva Park.
This project aims to find out if peer support can avert some of the adverse psychological consequences of aphasia, the language and communication disorder that affects about 15% of those who have a stroke. Stroke survivors with long-term aphasia will be trained as peer befrienders. They will be paired with individuals with aphasia who have had more recent strokes, e.g.
The Stroke Association is pleased to support the AllTrials campaign and has signed the petition for all clinical trials to be registered and published.
Our 'Supporting World Class Research in Scotland' booklet provides an overview of Stroke Association research successes in Scotland, over the years to present, including the new awards with the Chief Scientist Office.
The purpose of this research is to adapt an existing group psychological support course to make it suitable for stroke.
Postdoctoral Fellow: Dr Eirini Kontou
We are funding the KeMIST (Kent Medicine Support in Stroke and TIA) trial, which will use the views of stroke and Transient Ischaemic Attack (TIA) survivors to design a life-long medicines support service which will be provided by pharmacists. The KeMIST trial researchers are holding an open event to support the trial between 2pm and 4pm on Friday 25 November 2016.